Environmental signals mediated via the aryl hydrocarbon receptor (AHR) shape the developing immune system and influence immune function. Developmental exposure to AHR binding chemicals causes persistent changes in CD4 + and CD8 + T cell responses later in life, including dampened clonal expansion and differentiation during influenza A virus (IAV) infection. Naïve T cells require activation by dendritic cells (DCs), and AHR ligands modulate the function of DCs from adult organisms. Yet, the consequences of developmental AHR activation by exogenous ligands on DCs later in life has not been examined. We report here that early life activation of AHR durably reduces the ability of DC to activate naïve IAVspecific CD8 + T cells; however, activation of naïve CD4 + T cells was not impaired. Also, DCs from developmentally exposed offspring migrated more poorly than DCs from control dams in both in vivo and ex vivo assessments of DC migration. Conditional knockout mice, which lack Ahr in CD11c lineage cells, suggest that dampened DC emigration is intrinsic to DCs. Yet, levels of chemokine receptor 7 (CCR7), a key regulator of DC trafficking, were generally unaffected. Gene expression analyses reveal changes in Lrp1, Itgam, and Fcgr1 expression, and point to alterations in genes that regulate DC migration and antigen processing and presentation as being among pathways disrupted by inappropriate AHR signaling during development. These studies establish that AHR activation during development causes long-lasting changes to DCs, and provide new information regarding how early life environmental cues shape immune function later in life.
Introduction
The immune system develops during gestation and following birth. The environment experienced in utero and during early postnatal life can influence the immune system, leading to durable changes that influence health later in life. For instance, reports from human PLOS ONE | https://doi.org/10.1371/journal.pone.0207007 November 9, 2018 1 / 29 a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
activation affects the ability of DCs to activate naïve T cells using an established assay of APC function [35, 38] . Specifically, after respiratory infection we isolated DCs from the lung-draining mediastinal lymph nodes (MLN), the principle site of naïve T cell activation during IAV infection. We used an equivalent number of DCs from adult infected offspring of vehicle or TCDD exposed dams to activate naïve, CFSE-labeled TCR transgenic T cells ex vivo. To measure activation of CD8 + T cells, DCs were isolated from the MLN of developmentally exposed, infected adult offspring and co-cultured with naïve CD8 + T cells from naïve, untreated F5
TCR transgenic mice ( Fig 1A) . The TCR on CD8 + T cells of F5 mice recognizes a specific immunodominant peptide from IAV nucleoprotein (NP 366-374 ) [41] . Compared to DCs isolated from infected offspring of vehicle-treated dams, DCs from adult offspring of TCDDtreated dams had a two-fold reduction in the percentage of activated and proliferated (CD44 hi CFSE decay ) F5 CD8 + T cells (Fig 1B) . The number of CD44 hi CFSE decay CD8 + T cells was also reduced when F5 CD8 + T cells were cultured with DCs from offspring of TCDD treated dams (Fig 1C) . To examine CD8 + T cell differentiation, we measured IFNγ levels.
CD8
+ T cells cultured with DCs from offspring of TCDD-treated dams secreted roughly half as much IFNγ as CD8 + T cells stimulated by DCs from vehicle controls ( Fig 1D) . These data indicate that AHR activation during development reduced the ability of DCs to act as optimally effective APCs for naïve CD8 + T cells, as they stimulated lower levels of CD8 + T cell proliferation and differentiation. That is, activation of the AHR early in life, via direct treatment of the dam and vertical exposure to the fetus and neonate, leads to perturbation in the ability of DCs to stimulate naïve CD8 + T cells in adult offspring.
CD4
+ T cells are also important for host defenses against IAV and other respiratory pathogens [42] . Therefore, we investigated whether developmental exposure affected the ability of DCs to stimulate naïve CD4 + T cells. We used a similar approach to the ex vivo system with naïve CD8 + T cells, with two changes. We isolated CD4 + T cells from naïve, untreated OTII TCR transgenic mice, whose CD4 + T cells bear TCRs that recognize a peptide fragment of ovalbumin (OVA 323-339 ), and isolated DCs from developmentally exposed mice infected with a transgenic IAV that expresses this peptide: x31/OVAII [43, 44] . After infection, DCs from MLN of developmentally exposed adult offspring were co-cultured with naïve CFSE-labeled naïve CD4 + T cells from OTII TCR transgenic mice ( Fig 1E) . Regardless of whether the offspring were from vehicle or TCDD treated dams, DCs stimulated a similar percentage and number of OTII CD4 + T cells to become activated and proliferate (Fig 1F and 1G) . Furthermore, these CD4 + T cells produced similar levels of IFNγ ( Fig 1H) . Thus, in contrast to an impaired ability to stimulate CD8 + T cells, early life AHR activation does not appear to affect the ability of DCs to serve as APCs for naïve CD4 + T cells in the context of IAV infection.
In vivo distribution of DCs
In addition to affecting their ability to activate naive T cells, early life exposure could alter the distribution of DC within lymph nodes, which could contribute to poorer T cell responses during in vivo immune challenge. Therefore, we evaluated whether developmental exposure affects the in vivo distribution of DCs using immunohistochemistry and enumerated distinct DC subsets using analytical flow cytometry. One of the main sites where DCs act as APCs for naïve T cells is the T cell zone in lymph nodes. We utilized immunofluorescent microscopy to visualize the distribution of DCs in the MLN 3 days following IAV infection (Fig 2A) . The percentage of the MLN cross-sectional area that was positive for CD11c + staining was not different between adult offspring from vehicle or TCDD treated dams ( Fig 2B) . Moreover, the relative distribution of CD11c + staining in T and B cell zones was equivalent between treatment groups (Fig 2C) . Specifically, 43% and 54% of CD11c staining was in T cell zones of + T cell co-cultures, which show the combined data from two experiments. Each experiment was independently repeated at least 2 times with similar results. Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pone.0207007.g001
Developmental AHR activation alters dendritic cells PLOS ONE | https://doi.org/10.1371/journal.pone.0207007 November 9, 2018 MLNs from vehicle and TCDD groups, respectively. These results suggest that, at this macrolevel, developmental activation of AHR does not change the overall distribution of DCs between the T cell and B cell zones of the MLN during early stages of the response to IAV infection; a time of peak DC interaction with naïve T cells.
Activation of the AHR during development could also alter the number of distinct DC subsets within the MLN of the offspring. DCs are a heterogeneous population of cells, which are broadly categorized into conventional DCs (cDCs) and plasmacytoid DCs (pDCs) [45] [46] [47] . cDCs can be further divided into different subtypes. In the lung and lung-draining lymph nodes, two of the main types of cDCs are CD11b + and CD103 + DCs. Both of these cDC subsets emigrate from the lung during respiratory antigen challenge, and present antigen to naïve T cells in the lung-draining lymph nodes [35, 38, [48] [49] [50] [51] . We used multiple parameter analytical flow cytometry to identify and enumerate pDCs, total cDCs, CD11b + cDCs and CD103 cDCs, and pDCs in MLNs of mature offspring of vehicle ( Fig 3A) and TCDD-treated dams (Fig 3B) . Prior to IAV infection, there were significantly fewer cDCs, CD11b + cDCs in particular, in the MLN of offspring of the TCDD-treated dams (Fig 3C and 3D) . One day after IAV infection, we observed a reduction in number of total cDCs, CD11b + cDC and CD103 + cDC subsets, as well as pDCs (Fig 3C-3F ). Three days after infection, the number of cDCs and pDCs remained significantly decreased in adult offspring that were developmentally exposed compared to those from control dams (Fig 3C-3F) . We also observed a reduced percentage of CD103 + cDCs and increase in the proportion of CD11b + cDCs one day after IAV infection, CD11c cre mice from V or T dams treated with 10 μg/kg BW TCDD on GD14 and PND2. At each point in time, all wildtype offspring within a group were from a separate dam, n = 6-9 mice per group per day. Some Ahr fx/fx or Ahr fx/fx CD11c cre mice offspring within a group were from the same dam, n = 3-5 mice per group, because of limited number of offspring. Day 0 data are representative of 4 independent experiments, day 1 data are representative of 3 independent experiments, day 3 data are representative of 6 independent experiments with similar results. The experiment using Ahr fx/fx CD11c cre mice was performed once. An � indicates p � 0.05. Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pone.0207007.g003
Developmental AHR activation alters dendritic cells but these differences were not observed in uninfected offspring or 3 days after infection (S1 Table) . In contrast to the MLN, in the lung there were no statistically significant differences in the percentage or number of cDCs or pDCs between treatment groups prior to or after infection (S1 Fig and S1 
Developmental AHR activation reduces DC migration
The decreased number of DCs in the MLN of offspring that were developmentally exposed to TCDD could reflect that developmental exposure increases DC death and/or affects DC migration. Apoptotic and dead DCs were identified using flow cytometry. Regardless of whether we examined DCs prior to or after infection, we did not observe any statistically significant differences in apoptotic or dead DCs from the MLN or lungs of offspring from TCDD-treated dams compared to vehicle offspring (S2 Fig) . In contrast, we found evidence that developmental exposure affects DC migration. (Fig 4C-4F, histograms) . Furthermore, this reduction spanned all DC subsets, and there were significantly fewer CFSE + cDCs, CD11b + , CD103 + , and pDCs in the MLN 3 days after infection in offspring of TCDD-treated dams (Fig 4C-4F , bar graphs). These findings indicate that AHR activation during development leads to DCs with a diminished capacity to emigrate from the lung to lymph node during infection.
To further test whether developmental exposure blunts DC migration properties, we used a well-established in vitro DC migration assay. Specifically, we generated DCs from the bone marrow of naïve adult offspring of dams treated with either vehicle or TCDD (Fig 5A) , and measured their ability to migrate towards a concentration gradient of CCL21 in a Transwell system. Consistent with prior reports, maternal treatment with this low dose of TCDD did not alter the total number of bone marrow cells obtained [29] , nor did it affect the number of immature BMDCs generated after day 8 in culture, nor the number of mature BMDCs (Fig 5B-5D ). However, fewer DCs from the TCDD-exposed group migrated from the upper toward the lower chamber, containing CCL21 (Fig 5E) . Area under the curve (AUC) analyses further support that the proportion of migrated DCs was significantly reduced for BMDCs generated from animals that were developmentally exposed to TCDD (Fig 5F) . These results further support that early life activation of the AHR results in DCs with a reduced ability to migrate towards an optimal stimulus.
number of the indicated DC subset that was CFSE + . Error bars depict ± SEM. An � indicates p � 0.05. All offspring within a group are from a separate dam (n = 3-7 per group). Data are from one experiment that is representative of two independent experiments. Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pone.0207007.g004 Given that major regulators of leukocyte migration are CCL21 and chemokine receptor 7 (CCR7), the receptor that CCL21 binds [54-56], we next examined whether developmental exposure decreased in vivo levels of CCL21, or diminished CCR7 expression on DCs. Using ELISAs to measure CCL21 in tissue homogenates, the levels of CCL21 were about nine times higher in the MLN than the lung (Fig 6A and 6B) . However, prior to and three days after infection, the levels of CCL21 in the lung and MLN were equivalent between developmental exposure groups (Fig 6A and 6B ). Using BMDCs from developmentally exposed offspring, there was no difference in the percentage of BMDCs that were CCR7 + or in the mean fluorescence intensity (MFI) of CCR7 on BMDCs from these two exposure groups (Fig 6C and 6D) . Similarly, in the lung the relative level of expression of CCR7 on DCs, examined using MFI, was not reduced on any of the DC subsets examined (Fig 6E-6H ). Moreover, there were no differences in the percentage or number of CCR7-expressing DC subsets in the lung (S1 Table) . In contrast, cDCs, specifically CD11b + cDCs, in the MLN of developmentally exposed offspring had significantly reduced CCR7 levels 1 day after infection (Fig 6I-6L ). In addition to, the proportion of all cDCs and of CD11b + cDCs that were CCR7 + on day 1 after infection in the MLN was also reduced (S1 Table) . However, this decrease in CCR7 expression was transient, as the MFI and percentage of CCR7 + DCs in the MLN was not different between the two groups prior to infection or 3 days after infection.
To further determine whether developmental exposure affects CCR7 levels specifically on the DCs that trafficked to the MLN from the infected lung, we compared CCR7 levels on CFSE + and CFSE -DCs in the MLN (Fig 7) . Overall, the expression of CCR7 was higher on CFSE + cDC subsets (Fig 7A-7D ) compared to CFSE -cDCs (Fig 7E-7H ). Also, a greater proportion of the CFSE + cDCs were CCR7 + , which further suggests that CCR7 is higher on cDCs in the MLN that emigrated from the lung. However, between the treatment groups, the MFI of CCR7 was not significantly different on any of the DC subsets examined (Table 1 ). These data suggest that early life AHR activation does not change CCR7 levels on DCs that have emigrated from the lung to the MLN.
Developmental activation of AHR alters gene expression in DCs
Given that early life AHR activation reduced the capacity of DCs to stimulate naïve CD8 + T cells and also affected DC trafficking, we next wanted to identify DC-specific functional pathways that are altered by developmental AHR activation. To uncover cellular pathways in DCs affected by developmental exposure, we utilized a PCR array that measured 84 genes involved in DC function. In mature BMDCs from offspring of dams that were treated with vehicle or TCDD, 71 of 84 genes were expressed. Of these genes, 14 were differentially expressed in BMDCs from offspring of TCDD-treated dams (Fig 8) , while the remaining 58 genes were not significantly different between the two exposure groups. Interestingly, all 14 of the differentially expressed genes (DEGs) were down-regulated in the TCDD group, compared to BMDCs from the control group (Table 2 ). The 14 DEGs encode proteins that contribute to five aspects of DC function: antigen processing and presentation, cellular adhesion and migration, chemokines, cellular survival and differentiation, and signal transduction. Using the same PCR array system, we compared gene expression in DCs from MLN of developmentally exposed mice. In MLN-derived DCs, there were 16 DEGs, while 63 genes were not significantly different between the two exposure groups and 5 genes were not detected (Fig 9) . The number of DEGs was similar in BMDCs and MLN-derived DCs. Yet, in contrast to DEGs in BMDCs, the direction of change among the DEGs from MLN-derived DCs was mostly increased (Fig 9) . The differences in the change in direction may reflect differences in the timing of DC stimulation relative to gene expression assessment and differences in DC activation in vitro versus in vivo. Despite these differences, the DEGs in DCs from MLN were similar to BMDCs with regard to the functional pathways affected. Similar to BMDCs, pathways changed by developmental exposure include antigen processing and presentation, cellular adhesion and migration, cellular survival and differentiation, chemokines, cytokines, and signal transduction pathways (Table 3) . Thus, although only three DEGs were the same in MLN DCs and BMDCs (Lrp1, Fcgr1 and Itgam), the overall pathways affected by developmental exposure were similar in DCs from the MLN and bone marrow.
In addition to the genes in the PCR array, we measured Ccr7, Ido1 and Cyp1a1 expression. There were no statistically significant differences in the expression of Ccr7 in BMDCs or MLN DCs from the TCDD group compared to DCs from the vehicle exposed offspring (Fig 8 and  S2 Table) . This corresponds with the general lack of durable differences in CCR7 protein expression on DCs in offspring of vehicle and TCDD treated dams (Fig 6) . Cyp1a1 and Ido1 represent two genes that are upregulated by direct exposure to AHR agonists. The expression levels of Ido1 in BMDCs or MLN DCs were not different between treatment groups (S2 Table) . Consistent with prior reports [7], we did not detect Cyp1a1 expression in MLN DCs from either exposure group (S2 Table) . This suggests that the DEGs in cells from adult offspring are not direct AHR target genes, but instead reflect altered transcriptional regulation in DCs that is triggered by AHR activation earlier in life.
Discussion
AHR activation during development has a lasting impact on adaptive immune responses in the offspring, modulating T cell responses in several model systems, including viral infection. Yet, our understanding of how early life AHR activation specifically affects functional properties of many types of leukocytes is scant. For instance, although DCs are critical for the initiation of adaptive immunity, the consequences of AHR activation during development on DCs has not been established. Given that direct AHR signaling modifies DC function, it is logical to hypothesize that exposure to exogenous AHR ligands during development could affect this important leukocyte lineage later in life. In this report, we show that developmental activation of the AHR influences some aspects of DC function, such as their ability to stimulate naïve CD8 + T cells and their ability to migrate, while leaving other DC characteristics without per- Developmental AHR activation alters dendritic cells Genes in MLN DC are up-regulated after early life AHR activation. CD11c + cells (DC) were enriched from the MLNs of adult offspring from dams that were exposed to vehicle control or TCDD. The heat map shows significantly differentially expressed genes (DEGs) in DC from vehicle or TCDD exposed offspring 3 days after IAV infection (HKx31) based on the average log2(fold change) relative to naïve DCs from 3 replicate samples per group and are ordered from most significantly up-regulated to most significantly down-regulated in the vehicle group. Genes were considered significantly different between vehicle and TCDD groups when p � 0.05. All offspring within a group are from a separate dam (n = 12 mice per replicate, 3 independent replicates per group). Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pone.0207007.g009 high affinity immunoglobulin gamma Fc receptor I (FCGR1), which mediates internalization of antigen-IgG complexes and DC cross presentation [67, 68] . Lrp1 encodes a scavenger receptor called low density lipoprotein receptor-related protein 1 or LRP1, which aids in the internalization of antigen-heat shock protein complexes [69] [70] [71] . Both FCGR1 and LRP1 play a role in cross-presentation of exogenous antigen in the context of MHCI on DCs [67] [68] [69] [70] [71] [72] . Thus, disruption of cross-presentation is a mechanism by which early life activation of the AHR could dampen DC:CD8 + T cell interactions. Moreover, this provides a potential explanation for how AHR activation during development affects the ability of DCs to activate naïve CD8 + , but not CD4 + T cells, following infection. In addition to cross presentation, inappropriate triggering of the AHR during development may also affect other mechanisms that govern DC and T cell interactions, such as the frequency and duration of DC:T cell contacts, antigen uptake, availability, and the balance between immunostimulatory and regulatory DC functions [73] [74] [75] [76] . Another key finding is that AHR activation during development reduced DC migration later in life. Studies of direct AHR activation point to an emerging role for the AHR in the control of leukocyte migration. For example, direct exposure to TCDD reduced bone marrow cell migration in vivo [77] . In other studies, in vivo DC migration from the lung to the MLN during IAV infection was reduced upon AHR activation [35] . AHR signaling also affects neutrophil trafficking, although it may do so indirectly, via signaling in non-hematopoietic cells, and the direction of change depends upon the stimuli [30, [78] [79] [80] [81] . Also, although AHR signaling affects neutrophil recruitment, it does not affect the number of neutrophils in peripheral tissues in the absence of antigen challenge [78] [79] [80] . Similarly, we did not observe differences in the number of DCs in lungs before or after infection. Yet, when cued to emigrate, such as in vivo during infection or ex vivo in response to a chemokine gradient, fewer DCs migrated. Developmental AHR activation alters dendritic cells
Although we observed fewer DCs emigrating from the lung to the MLN upon infection, it is possible that rather than failing to migrate, the DCs are migrating improperly and accumulating in a different anatomical site. Thus, while early life AHR activation influences DC migration properties, it likely does so in conjunction with, or in the context of, other signals to the DCs. Although recent studies have linked direct AHR activation to increases in CCR7 expression levels [32, 82] , developmental exposure led to only modest and transient decreases in CCR7 levels on cDCs in the MLN, and did not alter CCR7 expression levels on BMDCs or lung DCs. Thus, it is likely that other factors that regulate DC migration are affected by developmental AHR activation. For instance, signals that promote cellular cytoskeletal rearrangement or adhesion could be altered as a result of early life AHR activation in DC. Candidates revealed by gene expression analyses include molecular regulators of cell adhesion and migration, such as Lrp1 and Itgam (CD11b). CD11b is one of four β 2 integrins involved in cell signaling, migration, and in DC-T cell interactions [83] . In addition to playing a role in cross-presentation, LRP1 signaling can influence cell migration [84] [85] [86] [87] , and LRP1 directly associates with CD11b and modulates cellular adhesion [84, 88] . Interestingly, differential expression of Lrp1 and Itgam was observed in both BMDCs and in DCs from the MLN of developmentally exposed mice. This further suggests a possible central role for AHR-mediated changes in these genes, or in the upstream regulators of the expression of these genes. An important consideration in the interpretation of gene expression analyses in DCs isolated from the MLN is that these results are skewed by preferentially reflecting gene expression in the DC populations that have already migrated to the lymph nodes. This limitation is mitigated by our observation that in developmentally exposed mice, decreased DCs number reflects a reduction in all subsets examined.
The changes observed in DCs appear to be inherent to the DC lineage, and suggest that triggering AHR during development causes long-lasting programming of DCs. Evidence includes the differences in ex vivo APC function, diminished DC migration, including abrogation of the reduced DC number in MLNs of developmentally exposed mice lacking Ahr in the CD11c lineage. Given that the lifecycle of DCs is several days to a few weeks [89] [90] [91] , the DCs evaluated at maturity are not present in the fetus and neonate. That is, the DCs interrogated at maturity are not directly exposed to the exogenous AHR ligand given to the dams. Instead, it is likely that DC progenitor cells, such as a monocyte-dendritic cell progenitors (MDP) or common dendritic cell progenitors (CDP), are affected by early life AHR activation. Changes in DC function observed in developmentally exposed offspring may reflect alterations in epigenetic programming in the DC lineage. Epigenetic regulatory mechanisms, such as DNA methylation, influence gene expression and cellular function [92] . Although not extensively studied, developmental exposure to other environmental factors, such as being born to an asthmatic mother, alters DNA methylation marks in DCs of the offspring [57, 58] . Furthermore, early life activation of the AHR modifies DNA methylation patterns and gene expression in CD8 + T cells of adult offspring [7] . Thus, it is possible that inappropriate AHR activation during development alters DNA methylation, and potentially other epigenetic regulatory mechanisms, in the DC lineage, leading to durable changes in DC functions later in life.
The research reported here focuses on how developmental exposure to a representative AHR agonist influences the response of DCs during acute, primary IAV infection. DCs are fundamental to appropriate immune responses to many pathogens, to vaccines, and to establishing anti-tumor immunity. Thus, the significance of these initial findings extends beyond IAV infection, and suggest developmental exposure to AHR-binding substances affects DC responses in other contexts. More broadly, these data support the idea that the early life environment shapes DC function in an enduring manner, influencing immune function into adulthood. Given that DCs are critical regulators of adaptive immune responses during may different types of immune challenges, this work reveals that AHR-mediated events influence DCs may be an important factor in many communicable, and non-communicable, diseases.
Materials and methods

Mice
C57Bl/6 (B6) and B6.Cg-Tg (Itgax-cre) 1-1Reiz/J (CD11c cre ) [93] mice (5-6 weeks old) were purchased from the National Cancer Institute (Frederick, MD) GA-3') and OL4088 (5'-GGT ACA AGT GCA CAT GCC TGC-3'); CD11c Cre transgene forward (5'-ACT TGG CAG CTG TCT CCA AG-3') and CD11c Cre transgene reverse (5'-GCG AAC ATC TTC AGG TTC TG-3'). All mice are housed in microisolator cages in a specific pathogen-free facility at the University of Rochester Medical Center, and are provided food and water ad libitum. Animals were sacrificed using anesthetic overdose, followed by a secondary method. All animal treatments were conducted with approval of Institutional Animal Care and Use Committee and Institutional Biosafety Committee of the University of Rochester.
Developmental exposure
Nulliparous female B6 mice were housed with B6 males, and checked daily for the presence of a vaginal plug; designated day 0 of gestation (GD0). Impregnated B6 mice were singly housed and treated with 1 μg TCDD/kg body weight or the peanut oil vehicle control (Vehicle) by gavage on GD 0, 7, and 14 and 2 days after parturition (PND2 , which encodes a protein with 10 times lower affinity for TCDD than the Ahr b/b expressed by B6 mice [52, 80, 95] . The timing of dosing of impregnated Ahr fx/fx mice was altered due to pup death that occurred when TCDD was administered during early pregnancy (i.e., dams were not treated on GD0 and GD7). For the dosing solution, TCDD (�99% purity; Cambridge Isotope Laboratories, Woburn, MA) was dissolved in anisole and diluted in peanut oil. The vehicle control consisted of peanut oil containing an equivalent concentration of anisole (0.01%). No culling of litters was performed, and offspring were weaned at 20-21 days of age.
Viral infection
Adult offspring (8-12 weeks of age) of TCDD-or vehicle-treated dams were anesthetized by intraperitoneal (i.p.) injection of avertin (2,2,2-tribromoethanol; Sigma Aldrich, Milwaukee, WI) and inoculated intranasally (i.n.) with 25 μl sterile PBS containing 120 hemagglutinating units (HAU) of influenza virus strain A/HK/x31 (x31; H3N2), 1x10 7 plaque forming units (PFU) of A/Memphis/102/72 (Mem/102; H3N2), or 8.25x10 5 PFU of A/HK/x31/OVAII (x31/ OVAII; H3N2; [44] ). This work was conducted with prior review and approval of the Institutional Biosafety Committee of the University of Rochester.
Isolation of immune cells
Single-cell suspensions of mediastinal lymph node (MLN), lung, bone marrow, and spleen cells were obtained as previously described [29, 35, 96] . Briefly, MLNs were disrupted between the frosted ends of 2 microscope slides, and digested with collagenase-containing media for 25 min at 37˚C in 5% CO 2 (RPMI 1640 medium containing 1 mg/mL collagenase A (Worthington Biochemical, Lakewood, NJ), 30 μg/mL DNase I (Roche), 2.5% FBS, and 10 mM HEPES).
Lungs were perfused with a solution of 0.6 mM EDTA (Invitrogen, Carlsbad, CA) in 1X phosphate buffered saline (PBS; Lonza, Walkersville, MD). Immune cells from the airways and interstitial spaces of the lung were obtained by digesting lungs with RPMI containing collagenase and DNAse I. Bone marrow (BM) cells were collected from the long bones suspended in complete RPMI (cRPMI) media (RPMI 1640 containing 10% FBS, 100 U/mL penicillin/streptomycin, 2 mM Glutamax-I (L-alanyl-L-glutamine dipeptide), 1 mM sodium pyruvate, and 1X non-essential amino acids; Gibco, Grand Island, NY). Naïve 
Flow cytometry
Cells were incubated with anti-mouse CD16/32, and stained with previously determined optimal concentrations of fluorochrome-conjugated mAbs. To identify DCs, antibodies against MHC class II (M5/114.15.2; I-A/I-E), CD11c (N418), CD11b (M1/70), CD103 (M290), B220 (RA2-6B2), PDCA-1 (ebio927). In some experiments, fluorochrome-conjugated antibodies for annexin V, live/dead, or CCR7 (4B12) were added. To identify T cells, antibodies against CD8 (53.67), Vβ11 (RR3-15), CD4 (GK1.5), Vβ5 (MR9-4), and CD44 (IM7) were used. Antibodies were purchased from eBioscience, BD Biosciences or BioLegend. Fluorescence minus one (FMO) controls were used to define gating parameters. Doublet discrimination and autofluorescent cell exclusion was included in the gating strategy. Data acquisition was performed using LSR-II cytometers (BD BioSciences) and data analyses were performed using FlowJo software (Tree Star, Ashland, OR).
Ex vivo assay of APC function
DCs were isolated from pooled MLN of Mem/102-or X31/OVAII-infected adult offspring (>30 mice per group) and enriched using a Mouse CD11c Microbead Kit (Miltenyi Biotec, Auburn, CA) [35, 38] . On the same day, naïve T cells from spleens of F5 or OTII mice were isolated using MagCelect Mouse Naïve CD8 + T Cell Isolation Kit or Naïve CD4 + T Cell 
Fluorescent immunohistochemistry
MLNs were snap frozen in OCT (Sakura Finetek, Netherlands). Using a cryostat, whole lymph nodes were cut into 10 μm thick sections, and 3-4 sections were placed onto coated slides. To determine the middle section, the total number of sections for each MLN was divided in half. The slide containing this section, and the slides with serial sections directly before and after it were stained, giving a total of 6-9 stained MLN sections per sample. Tissues were fixed with 2% paraformaldehyde (PFA), washed with PAB (1X phosphate buffer saline (PBS), containing 1% bovine serum albumin (BSA), and 0.1% sodium azide). Fixed slides were stained with a cocktail of the following fluorochrome-conjugated antibodies: CD11c PE (N418; 0.004 μg/μl; eBioscience), CD19 APC (1D3; 0.004 μg/μl; eBioscience), CD4 PerCP (RM4-5; 0.006 μg/μl; BD Biosciences), and LYVE-1 AF488 (ALY7; 0.01 μg/μl; eBioscience). An anti-mouse CD16/ CD32 (93; eBioscience) antibody was included to reduce nonspecific binding to Fc receptors. Fluorescent images were captured using a conventional fluorescence microscope with an Olympus DP80 camera and automated stage (Olympus Corporation, Waltham, MA). Olympus cellSens software was used to create montage fluorescent images of each MLN. Image analysis was performed on raw images using an open source software distribution of ImageJ called Fiji (https://fiji.sc/) [98] . Determination of T cell zones and B cell zones was performed using Fiji's polygon tool, by drawing demarcations based on anti-CD19 and anti-CD4 staining.
Images were thresholded to determine the percentage of CD11c positive area across the entire surface area, and in each compartment.
In vivo DC migration
CFSE was diluted in sterile endotoxin-free PBS to 8 mM. Mice were anesthetized and diluted CFSE was instilled (i.n.) 54 h after infection with IAV (HKx31), to label all cells in the respiratory tract [35, 53] . After 18 h of CFSE treatment (3 d after infection), mice were sacrificed and MLN cells were stained with antibodies against MHCII and CD11c to identify DCs that had migrated from the lung (CFSE 
BMDC generation and ex vivo migration assay
To generate bone marrow derived DCs (BMDCs), bone marrow cells (2x10 6 cells/well) were cultured in cRPMI supplemented with 25 ng/mL mouse GM-CSF and 10 ng/mL mouse IL-4 (Peprotech, Rocky Hill, NJ) for 8 days [99, 100] . On day 8, immature BMDCs were harvested and resuspended in cRPMI, and treated for 24 h with LPS (1 μg/mL) to create mature DCs [99, 101] . After 24 h, mature BMDCs were enumerated, and used in migration assays, stained for flow cytometry, or had RNA extracted. Migration towards a gradient (0-1000 ng/mL) of CCL21 (Peprotech, Rocky Hill, NJ) was determined by plating 2x10 5 BMDCs in the top wells of 8 μm pore, 96-well Transwell plates (Corning, Corning, NY) and enumerating cells in the bottom well after 2 h incubation at 37˚C.
Cytokine and chemokine analysis
Culture supernatants were collected from wells of DC:T cell co-cultures and the concentration of IFNγ was measured using a sandwich ELISA (BD Biosciences). CCL21 concentrations were measured in lung and MLN homogenates using a pre-fabricated CCL21 ELISA kit (R&D Systems, Minneapolis, MD) per the manufacturers protocol.
Real-time PCR analysis
Total RNA was isolated from LPS stimulated BMDC with an RNeasy Mini Kit (Qiagen, Germantown, MD) and cDNA generated using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). RNA was isolated from CD11c + DC enriched from MLNs using an RNeasy Plus Kit (Qiagen, Germantown, MD) and cDNA conversion was performed using a NuGEN WT-Ovation PicoSL Kit ( or iQ SYBR Green Supermix (Bio-Rad, Hercules, CA). Changes in gene expression were determined using the 2 -ΔΔC T method [102] .
Statistical analyses
The dam was defined as the statistical unit for all experiments, because the dams, not her offspring, were directly treated with TCDD or vehicle control. For most experiments, experimental groups were comprised of 6-9 adult male offspring from separate dams. For some ex vivo assays, pooling of mice from within the same exposure group was required to yield ample biological material. Statistical analyses were performed using JMP software (SAS Institute, Cary, NC). A two-way ANOVA, followed by a Tukey HSD post hoc test, was used to compare differences between multiple independent variables (e.g. multiple genotypes, over time, or across different concentrations). Differences between means of vehicle or TCDD groups at a single point in time were evaluated using a Student's t-test. Means were considered significantly different when p-values were less than or equal to 0.05. Error bars on all graphs represent the standard error of the mean (SEM). 
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